SCHEMBL8937418

SCHEMBL8937418

CCOC(=O)C(C)C(O)(c1ccc(OC)cc1)c1ccc(OC)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.44
EPHX2 P34913 1/20 0.42
KMT2A Q03164 4/20 0.42
HDAC3 O15379 2/20 0.42
HDAC4 P56524 2/20 0.42
HDAC1 Q13547 2/20 0.42
HDAC7 Q8WUI4 2/20 0.42
HDAC2 Q92769 2/20 0.42
HDAC10 Q969S8 2/20 0.42
HDAC11 Q96DB2 2/20 0.42
HDAC8 Q9BY41 2/20 0.42
HDAC6 Q9UBN7 2/20 0.42
HDAC9 Q9UKV0 2/20 0.42
HDAC5 Q9UQL6 2/20 0.42
GLA P06280 1/20 0.42
HSD17B10 Q99714 3/20 0.42
LMNA P02545 2/20 0.42
ALOX15 P16050 1/20 0.42
APEX1 P27695 1/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9855275 0.83 MAPT (0.43) ALDH1A1EPHX2KMT2AHSD17B10LMNA
SCHEMBL8937536 0.80 LDHA (0.47) ALDH1A1HSD17B10LMNAALOX15APEX1
SCHEMBL10977789 0.79 KIF11 (0.46) ALDH1A1EPHX2KMT2ALMNAMAPK1
1,4-Dimethoxybenzene SCHEMBL27707743 0.78 KMT2A (0.50) ALDH1A1EPHX2KMT2AHDAC3HDAC4
SCHEMBL13221585 0.76 ALDH1A1 (0.46) ALDH1A1EPHX2KMT2AHDAC3HDAC4
SCHEMBL10980312 0.75 ALDH1A1 (0.44) ALDH1A1EPHX2KMT2AHDAC3HDAC4
SCHEMBL21501145 0.74 ALDH1A1 (0.46) ALDH1A1EPHX2KMT2AHDAC3HDAC4
SCHEMBL13498008 0.74 CYP3A4 (0.58) ALDH1A1HSD17B10LMNAALOX15APEX1
SCHEMBL490908 0.73 TDP1 (0.50) KMT2AHDAC3HDAC4HDAC1HDAC7
SCHEMBL5112826 0.73 LMNA (0.61) ALDH1A1EPHX2KMT2AHDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5559109-A Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist SANKKO COMPANY, LIMITED (JP) 1996-09-24 US disclosed
EP-0395446-B1 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists SANKYO CO (JP) 1995-03-01 EP disclosed
US-5369106-A N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists SANKYO COMPANY, LIMITED (JP) 1994-11-29 US disclosed
US-5192766-A Platelet activating factor antagonist SANKYO COMPANY, LIMITED (JP) 1993-03-09 US disclosed
EP-0395446-A2 N-acryloylpiperazine derivatives, their preparation and their use as paf antagonists Sankyo Company Limited (JP) 1990-10-31 EP disclosed